Map of Pancreatica Walks and Runs

Category Archives: Medical Research

Daniel Von Hoff Inducted into Lederberg Society for Work on Abraxane in Pancreatic Cancer

One of our favorite physician pancreatic cancer researchers, Daniel Von Hoff, has been honored by induction into the Joshua Lederberg Society on February 13, 2014 primarily for his work in shepherding the development of Abraxane (nab-paclitaxel) in combination with gemcitabine for the treatment of advanced cancer of the pancreas. This award is presented by Celgene […]

Share Button

MORE STROMA: Inhibiting Fibroblast Growth Factor Disrupts Pancreatic Cancer Cell Invasion

As mentioned, stromal tissue can account for as much as 90% of the bulk in pancreatic cancer tumors. Thought in the past to have been relatively inert, it is increasingly clear that this dense tissue arising from a desmoplastic process is surprisingly dynamic. Thus, it is heartening to encounter a number of recent serious research […]

Share Button

Gemzar for Post-Whipple Chemotherapy in Pancreatic Cancer?

The standard chemotherapy agent for adjuvant treatment of pancreatic cancer typically has been Fluorouracil (5-FU) based. But there have been other adjuvant agents and modalities for pancreatic cancer under study including gemcitabine, combined chemotherapy (multiple drug agents), and chemoradiation. On behalf of the German Study Group for Pancreatic Cancer (a branch of the German Cancer […]

Share Button
Page 4 of 18« First...23456...10...Last »